Hyperglycemia is a prevalent metabolic disease that belongs to the group of conditions known as diabetes mellitus. Due to numerous, long-lasting complications, diabetes affects practi-cally all of the body's systems (Janmohammadi et al., 2010). Diabetes has become an epidemic on a global scale. According to the International Diabetes Federation (IDF), 628 million people will have diabetes mellitus by the year 2045, up from 425 million in 2017. Currently, Sub-Saharan Africa has the highest global diabetes burden (Cho et al., 2018, Elbarsha et al., 2019). In 2013, diabetes resulted in 56 million Disability Adjusted Life Years (DALYs) and 1.3 million fatalities (2.4% of all deaths). From 589.9 per 100,000 in 1990, the DALY rate for diabetes climbed to 883.5 per 100,000 in 2013. Ageing and age-specific DALY rates increased by 31.8 and 53.9%, respectively, while population growth increased by 62.9% and 148.6%, respectively, during the 1990s to 2013 (Moradi-Lakeh et al., 2017).

.